ANGELA A ESCALANTE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner LUBBOCK, TX NPI 1457582736

General Payments — all program years on this page

$1,948.59

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 117
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $313.04 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $313.0417

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Acerta Pharma LLC $194.0411
GlaxoSmithKline, LLC. $37.502
DEXCOM, INC. $24.761
DePuy Synthes Sales Inc. $22.191
Bayer HealthCare Pharmaceuticals Inc. $18.041
Novo Nordisk AS $16.511

By program year

Program yearAmountRecords
2021 $922.9258
2022 $367.5622
2023 $345.0720
2024 $313.0417

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077895862 DePuy Synthes Sales Inc. $22.19 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086354130 Bayer Healthcare Pharmaceuticals Inc. $18.04 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100397464 Novo Nordisk Inc $16.51 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104264629 AstraZeneca Pharmaceuticals LP $18.75 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104325114 AstraZeneca Pharmaceuticals LP $19.88 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104478480 AstraZeneca Pharmaceuticals LP $14.66 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104580150 AstraZeneca Pharmaceuticals LP $15.85 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104627426 AstraZeneca Pharmaceuticals LP $15.85 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104724165 AstraZeneca Pharmaceuticals LP $19.62 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105323344 AstraZeneca Pharmaceuticals LP $15.39 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105554350 AstraZeneca Pharmaceuticals LP $17.78 01/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105561720 AstraZeneca Pharmaceuticals LP $15.85 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105744308 AstraZeneca Pharmaceuticals LP $22.87 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105870963 AstraZeneca Pharmaceuticals LP $17.54 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115783752 GlaxoSmithKline, LLC. $18.34 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116723551 GlaxoSmithKline, LLC. $19.16 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153348858 Dexcom, Inc. $24.76 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.